CME Group Inc. logo

CME Group Inc. (CME)

Market Open
24 Feb, 20:39
NASDAQ (NGS) NASDAQ (NGS)
$
318. 50
+4.5
+1.43%
$
108.96B Market Cap
24.7 P/E Ratio
5% Div Yield
1,626,586 Volume
9.17 Eps
$ 314
Previous Close
Day Range
313.27 318.96
Year Range
247.08 318.95
Want to track CME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CME earnings report is expected in 56 days (21 Apr 2026)
CME Group (CME) Q4 Earnings and Revenues Top Estimates

CME Group (CME) Q4 Earnings and Revenues Top Estimates

CME Group (CME) came out with quarterly earnings of $2.52 per share, beating the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.37 per share a year ago.

Zacks | 1 year ago
CME Group: Q4 EPS Surpasses Expectations

CME Group: Q4 EPS Surpasses Expectations

CME Group (CME -0.03%), a leading derivatives marketplace known for options and futures trading, reported fourth-quarter 2024 earnings results on Wednesday, Feb. 12, that topped analysts' consensus expectations. Adjusted earnings per share (EPS) of $2.52 beat the estimate of $2.45.

Fool | 1 year ago
CME Group Gears Up to Report Q4 Earnings: Here's What to Expect

CME Group Gears Up to Report Q4 Earnings: Here's What to Expect

CME's fourth-quarter results are likely to reflect a diverse product portfolio, increased volatility and a strong market position.

Zacks | 1 year ago
Ahead of CME (CME) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Ahead of CME (CME) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Evaluate the expected performance of CME (CME) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks | 1 year ago
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
'No-Brainer' Buys: If I Could Only Own 2 Dividend Stocks

'No-Brainer' Buys: If I Could Only Own 2 Dividend Stocks

I believe we are entering the perfect stock-picking market as valuations shift. With economic growth widening, opportunities beyond big tech are emerging. One of my highest-conviction picks is a unique landowner. Its high-margin business model benefits from oil, water, and data center deals. The other pick is a high-margin financial giant. With strong cash flow, minimal capital needs, and dividend potential, I see massive upside ahead.

Seekingalpha | 1 year ago
CME to give Robinood traders access to futures including gold and silver

CME to give Robinood traders access to futures including gold and silver

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Kitco | 1 year ago
U.S. tariffs, Chinese rebates, and the rise of short-term options: CME Group's key developments in 2025 metals markets

U.S. tariffs, Chinese rebates, and the rise of short-term options: CME Group's key developments in 2025 metals markets

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

Kitco | 1 year ago
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
100% Payout Cash Flow Kings - 2 Of My Favorite High-Yield Stocks

100% Payout Cash Flow Kings - 2 Of My Favorite High-Yield Stocks

Rising interest rates and a significant portion of U.S. debt maturing soon pose a major risk to the economy and stock market. Elevated bond yields provide an attractive alternative to equities, making the market vulnerable to further increases in longer-term bond rates. Inflation remains a critical risk, potentially leading to higher fed funds rates and bond yields, which could negatively impact stock prices.

Seekingalpha | 1 year ago
CME Group Stock Trades Above 50-Day SMA: What Should You Do Now?

CME Group Stock Trades Above 50-Day SMA: What Should You Do Now?

A strong global presence, a compelling product portfolio, focus on over-the-counter clearing services and a solid capital position poise CME well for growth.

Zacks | 1 year ago
CME Group: Exchanges And Data Will Keep Growing, And So Could Its Dividend

CME Group: Exchanges And Data Will Keep Growing, And So Could Its Dividend

CME Group gets upgraded to buy, from my prior hold rating over a year ago, with renewed confidence in its future top and bottom-line growth potential. The firm could be driven by increased trading volume, but also growing demand for data analytics solutions. The dividend case is strong: a +4% yield, proven dividend growth, and a safe payout ratio.

Seekingalpha | 1 year ago
Loading...
Load More